As of Apr 29
| +0.003 / +1.71%|
The 1 analysts offering 12-month price forecasts for Immune Therapeutics Inc have a median target of 20.00, with a high estimate of 20.00 and a low estimate of 20.00. The median estimate represents a +11,135.96% increase from the last price of 0.18.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.